{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:59:20Z","timestamp":1787579960263,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102166","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:11:52Z","timestamp":1764259912000},"page":"102166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9130-8463","authenticated-orcid":false,"given":"Yousef","family":"Almahanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5607-0698","authenticated-orcid":false,"given":"Francisco","family":"Idalsoaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-4930","authenticated-orcid":false,"given":"Luis Antonio","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Almohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Nong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Bajunayd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-9371","authenticated-orcid":false,"given":"Rokhsana","family":"Mortuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeemin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Abaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-7858","authenticated-orcid":false,"given":"Mohammad Qasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.aohep.2025.102166_bib0001","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102166_bib0002","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102166_bib0003","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2024.01.006","article-title":"Misclassified alcohol-related liver disease is common in presumed metabolic dysfunction-associated steatotic liver disease and highly increases risk for future cirrhosis","volume":"22","author":"Nasr","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102166_bib0004","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.gastha.2023.08.016","article-title":"High variability on alcohol intake threshold in articles using the MAFLD acronym","volume":"3","author":"Hernandez-Tejero","year":"2024","journal-title":"Gastro Hep Adv"},{"issue":"1","key":"10.1016\/j.aohep.2025.102166_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049767","article-title":"Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis","volume":"12","author":"Jarvis","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.aohep.2025.102166_bib0006","article-title":"Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD","volume":"15","author":"Huang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102166_bib0007","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2025.102166_bib0008","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.aohep.2025.102166_bib0009","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.aohep.2025.102166_bib0010","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.102166_bib0011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fmed.2020.00448","article-title":"Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities","volume":"7","author":"Idalsoaga","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.aohep.2025.102166_bib0012","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/hepr.13473","article-title":"Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: current concepts and perspectives","volume":"50","author":"Arab","year":"2020","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.aohep.2025.102166_bib0013","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/liv.15081","article-title":"Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use","volume":"42","author":"Decraecker","year":"2022","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.aohep.2025.102166_bib0014","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","article-title":"Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease","volume":"77","author":"Staufer","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2025.102166_bib0015","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.dld.2024.01.195","article-title":"You can\u2019t handle the truth! comparing serum phosphatidylethanol to self-reported alcohol intake in chronic liver disease patients","volume":"56","author":"Scholten","year":"2024","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.aohep.2025.102166_bib0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.35946\/arcr.v38.1.02","article-title":"Alcohol consumption in demographic subpopulations: an epidemiologic overview","volume":"38","author":"Delker","year":"2016","journal-title":"Alcohol Res"},{"key":"10.1016\/j.aohep.2025.102166_bib0017","doi-asserted-by":"crossref","unstructured":"Yoo J.J., Lee D.H., Kim S.G., Jang J.Y., Kim Y.S., Kim L.Y. Impacts of smoking on alcoholic liver disease: a nationwide cohort study. Front Public Health. 2024 Aug 7;12:1427131.","DOI":"10.3389\/fpubh.2024.1427131"},{"key":"10.1016\/j.aohep.2025.102166_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The Global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol [Internet]"},{"issue":"4","key":"10.1016\/j.aohep.2025.102166_bib0019","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2025.102166_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2021.10.005","article-title":"A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers","volume":"76","author":"Whitfield","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.102166_bib0021","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.102166_bib0022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2020.08.005","article-title":"Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study","volume":"82","author":"Mikolasevic","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.aohep.2025.102166_bib0023","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of >\/= 10\u2009% is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.aohep.2025.102166_bib0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2025.102166_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2025.102166_bib0026","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1016\/j.wneu.2018.12.011","article-title":"Anatomic relationship between ureter and oblique lateral interbody fusion access: analysis based on contrast-enhanced computed tomographic urography","volume":"123","author":"Xiao","year":"2019","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.aohep.2025.102166_bib0027","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41575-021-00527-0","article-title":"Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation","volume":"19","author":"Arab","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102166_bib0028","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-230X-14-166","article-title":"Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease","volume":"14","author":"Haflidadottir","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102166_bib0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2025.102166_bib0030","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14276","article-title":"Association of MASLD with the risk of extrahepatic cancers: a systematic review and meta-analysis of 18 cohort studies","volume":"54","author":"Zhou","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"16","key":"10.1016\/j.aohep.2025.102166_bib0031","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.3390\/jcm13164657","article-title":"MASLD-related hepatocarcinoma: special features and challenges","volume":"13","author":"Yag\u00fce-Caballero","year":"2024","journal-title":"J Clin Med"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:48:07Z","timestamp":1780649287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003916"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102166","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102166"}}